Publisher Correction: LifeTime and improving European healthcare through cell-based interceptive medicine (Nature, (2020), 587, 7834, (377-386), 10.1038/s41586-020-2715-9)
10.1038/s41586-021-03287-8
Saved in:
Similar Items
-
Association between early cumulative fluid balance and successful liberation from invasive ventilation in COVID-19 ARDS patients — insights from the PRoVENT-COVID study: a national, multicenter, observational cohort analysis
by: Sanchit Ahuja, et al.
Published: (2022) -
Multidrug resistant 2009 a/h1n1 influenza clinical isolate with a neuraminidase i223r mutation retains its virulence and transmissibility in ferrets
by: van der Vries E., et al.
Published: (2019) -
Longitudinal respiratory subphenotypes in patients with COVID-19-related acute respiratory distress syndrome: results from three observational cohorts
by: Lieuwe D.J. Bos, et al.
Published: (2022) -
Prognostication using SpO<inf>2</inf>/FiO<inf>2</inf> in invasively ventilated ICU patients with ARDS due to COVID-19 – Insights from the PRoVENT-COVID study
by: Jan Paul Roozeman, et al.
Published: (2022) -
How doctors actually (do not) involve families in decisions to continue or discontinue life-sustaining treatment in neonatal, pediatric, and adult intensive care: A qualitative study
by: Aranka Akkermans, et al.
Published: (2022)